BSEM - Company ID 0001658678
The table below shows BIOSTEM TECHNOLOGIES's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q2 2025 |
|---|---|---|
| Revenue | $7.90M | $10.96M |
| Cost of revenue | $3.06M | $685.18K |
| Gross profit | $4.84M | $10.28M |
| R&D | $733.62K | $1.96M |
| SG&A | $6.50M | $6.87M |
| Operating income | -$8.40M | $112.76K |
| Income tax | $0.00 | $167.34K |
| Net income | -$8.97M | $10.61K |
| EPS (diluted) | -$0.52 | $0.00 |
BIOSTEM TECHNOLOGIES reported annual revenue of $47.48M for fiscal year 2025. That is down 31.8% from $69.66M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.